Evidence map›Paper›PMID 30832224›Full record

ArticleMolecules (Basel, Switzerland)2019

In Vitro and In Vivo Anti-Inflammatory Effects of Polyphyllin VII through Downregulating MAPK and NF-κB Pathways.

Chao Zhang, Chaoying Li, Xuejing Jia, Kai Wang, Yanbei Tu, Rongchun Wang, Kechun Liu, Tao Lu, Chengwei He

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 85 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in pharmacology · 2025
    Review
  8. Review
  9. The role ofHeliyon · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Saponins ofMolecules (Basel, Switzerland) · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Chao ZhangSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China. zhangchao_0213@126.com.
Chaoying LiSchool of Pharmaceutical Sciences, Changchun University of Chinese Medicine, Changchun 130117, China. chaoying_li@126.com.
Xuejing JiaState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao 999078, China. jiaxjsicau@gmail.com.
Kai WangState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao 999078, China. wangkai6648@gmail.com.
Yanbei TuState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao 999078, China. tuyanbei1992@163.com.
Rongchun WangKey Laboratory for Drug Screening Technology of Shandong Academy of Sciences, Shandong Provincial Key Laboratory for Biosensor, Biology Institute of Shandong Academy of Sciences, Jinan 250014, China. 1wangrongchun@163.com.
Kechun LiuKey Laboratory for Drug Screening Technology of Shandong Academy of Sciences, Shandong Provincial Key Laboratory for Biosensor, Biology Institute of Shandong Academy of Sciences, Jinan 250014, China. hliukch@sdas.org.
Tao LuSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing 100029, China. taolu@bucm.edu.cn.
Chengwei HeState Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao 999078, China. chengweihe@umac.mo.ORCID 0000-0003-4701-2984
University of Macau · MOBeijing University of Chinese Medicine · CNBiology Institute of Shandong Academy of Sciences · CNChangchun University of Chinese Medicine · CN

Funding

Macao Science and Technology Development Fund 041/2016/AMacao Science and Technology Development Fund 070/2017/A2National Natural Science Foundation of China 81273883Research Fund of the University of Macau MYRG2018-00176-ICMS
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Inflammatory AgentsCyclooxygenase 2DinoprostoneDisease Models, AnimalEnzyme-Linked Immunosorbent AssayGene Expression RegulationHumansInflammationInterleukin-1betaInterleukin-6LipopolysaccharidesMAP Kinase Kinase 1MiceNF-kappa BNitric OxideAnti-Inflammatory AgentsCyclooxygenase 2DinoprostoneInterleukin-1betaInterleukin-6LipopolysaccharidesMAP Kinase Kinase 1NF-kappa BNitric OxideNitric Oxide Synthase Type IIpolyphyllin VIISaponinsTumor Necrosis Factor-alphaanti-inflammationmacrophagemicepolyphyllin VIIzebrafish

Identifiers

PMID30832224
PMCPMC6429153
OpenAlexW2916919652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.